US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%: Berlin Wednesday, July 16, 2025, 13:00 H ...

Heart disease is killing more women in Pakistan than previously understood, with female patients experiencing higher ...

Genetic changes can signal evidence of disease, but pinpointing which genes and what's changed can be difficult.

Researchers suggest that avoiding light at night may be a useful strategy to reduce cardiovascular disease risk.

‘I’m a Cardiologist, and This Is the One Type of Cheese (Yes, Cheese) I Swear by for Heart Health’ originally appeared on ...

It’s as if sudden cardiac arrest is met with a resigned shrug: If it’s nearly impossible to predict and even harder to treat, ...

Omega-3 fatty acids are a type of essential fats linked to many health benefits, such as heart health, reduced inflammation, ...

One arm is more likely that the other to hurt during a heart attack. It's the arm that shares nerves that branch from the ...

A comprehensive first-of-its-kind national study reveals that cardiovascular-kidney-metabolic syndrome (CKM) affects nearly 4 out of 5 American adults, highlighting a health concern that has grown ...

In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.